Richard Mulligan has an estimated net worth of $22.5 Million. This is based on reported shares across multiple companies, which include BIOGEN INC., Sana Biotechnology, Inc., ENZON PHARMACEUTICALS INC, Bausch Health Companies Inc., IMCLONE SYSTEMS INC, and INTERNATIONAL FLAVORS & FRAGRANCES INC.

2006 was Richard Mulligan's most active year for acquiring shares with 6 total transactions. Richard Mulligan's most active month to acquire stocks was the month of May. 2013 was Richard Mulligan's most active year for disposing of shares, totalling 14 transactions. Richard Mulligan's most active month to dispose stocks was the month of April. 2013 saw Richard Mulligan paying a total of $2,189,294.25 for 77,506 shares, this is the most they've acquired in one year. In 2013 Richard Mulligan cashed out on 89,830 shares for a total of $11,052,578.70, their largest year based on trade value.